Palovarotene,
R-667,
RG-667,
RO-3300074,
Palovarotene,
410528-02-8,
R-667,
RO-3300074,
UNII-28K6I5M16G,
R 667,
Ro 3300074,
(E)-4-(2-(3-((1H-pyrazol-1-yl)methyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid,
28K6I5M16G,
Palovarotene [USAN:INN],
RG-667,
Palovarotene(R 667),
Palovarotene (USAN/INN),
GTPL8276,
SCHEMBL4658931,
Clementia (proposed trade name),
CHEMBL2105648,
CLM-001,
YTFHCXIPDIHOIA-DHZHZOJOSA-N,
AOB87129,
BCP16664,
ZINC38467831,
AKOS030526809,
CS-2031,
DB12320,
SB16900,
AN-28279,
HY-14799,
RO3300074,
D09365,
Q-9307,
528P028,
4-[(E)-2-[1,1,4,4-tetramethyl-7-(pyrazol-1-ylmethyl)tetralin-6-yl]vinyl]benzoic acid,
4-((1E)-2-(5,5,8,8-Tetramethyl-3-(1H-pyrazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl)benzoic acid,
4-[(E)-2-(5,5,8,8-tetramethyl-3-pyrazol-1-ylmethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)vinyl]benzoic acid,
4-[(E)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic acid,
Benzoic acid, 4-((1E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-2-naphthalenyl)ethenyl)-,
Palovarotene [USAN],
D0H8OH,
Retinoid receptor agonist, Roche,
Ro-330074,
CID10295295,
CID 10295295,
B1175,
A12430,